134 related articles for article (PubMed ID: 33896834)
1. Decreased mean platelet volume is associated with microsatellite instability in colorectal cancer: A propensity score-matched analysis.
Wang W; Wang G; Fu S; Zhang B; Liu Z; Wang R
Cancer Biomark; 2021; 31(4):351-359. PubMed ID: 33896834
[TBL] [Abstract][Full Text] [Related]
2. The Association between Platelet Glycocalicin and High Microsatellite Instability in Colorectal Cancer.
Liu ZY; Jia QC; Wang W; Liu YX; Wang RT; Li JY
Gastroenterol Res Pract; 2022; 2022():9012063. PubMed ID: 35432525
[TBL] [Abstract][Full Text] [Related]
3. Relationship Between ABO Blood Group and Microsatellite Instability in Colorectal Cancer: A Retrospective Single-Center Study.
Karaoglan BB; Akyol C; Unal AE; Kuzu A; Savaş B; Utkan G
J Gastrointest Cancer; 2024 Mar; 55(1):281-286. PubMed ID: 37414939
[TBL] [Abstract][Full Text] [Related]
4. The significance of microsatellite instability in colorectal cancer after controlling for clinicopathological factors.
Kang S; Na Y; Joung SY; Lee SI; Oh SC; Min BW
Medicine (Baltimore); 2018 Mar; 97(9):e0019. PubMed ID: 29489646
[TBL] [Abstract][Full Text] [Related]
5. Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
Chen MH; Chang SC; Lin PC; Yang SH; Lin CC; Lan YT; Lin HH; Lin CH; Lai JI; Liang WY; Lu ML; Yang MH; Chao Y
Oncologist; 2019 Dec; 24(12):1534-1542. PubMed ID: 31292272
[TBL] [Abstract][Full Text] [Related]
6. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
[TBL] [Abstract][Full Text] [Related]
7. Investigation of ENO2 as a promising novel marker for the progression of colorectal cancer with microsatellite instability-high.
Cai J; Yang Y; Zhang L; Fang Y; Zhang Y; Tan M; Zhang J; Tang C; Ren H; Wang L; Xiang G; Xu F; Lan L; Li L; Zheng X
BMC Cancer; 2024 May; 24(1):573. PubMed ID: 38724951
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer.
Lin A; Zhang J; Luo P
Front Immunol; 2020; 11():2039. PubMed ID: 32903444
[TBL] [Abstract][Full Text] [Related]
9. Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: results from mCRC biomarker study.
Chang J; Lin G; Ye M; Tong D; Zhao J; Zhu D; Yu Q; Zhang W; Li W
BMC Cancer; 2019 Jan; 19(1):15. PubMed ID: 30612568
[TBL] [Abstract][Full Text] [Related]
10. Association between apoptosis inhibitor of macrophage and microsatellite instability status in colorectal cancer.
Huang WJ; Wang X; Zhang ML; Li L; Wang RT
BMC Gastroenterol; 2020 Nov; 20(1):373. PubMed ID: 33172404
[TBL] [Abstract][Full Text] [Related]
11. The value of single-source dual-energy CT imaging for discriminating microsatellite instability from microsatellite stability human colorectal cancer.
Wu J; Lv Y; Wang N; Zhao Y; Zhang P; Liu Y; Chen A; Li J; Li X; Guo Y; Wu T; Liu A
Eur Radiol; 2019 Jul; 29(7):3782-3790. PubMed ID: 30903331
[TBL] [Abstract][Full Text] [Related]
12. Beneficial influence of microsatellite instability on gelatinase-tissue inhibitors of metalloproteinase balance in colorectal cancer.
Thiéfin G; Dupont A; Guillou PJ; Vitry F; Bouche O; Yaziji N; Lagarde S; Maquart FX; Palot JP; Hornebeck W; Diebold MD
Anticancer Res; 2007; 27(1B):583-8. PubMed ID: 17348445
[TBL] [Abstract][Full Text] [Related]
13. Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers.
Kim CG; Ahn JB; Jung M; Beom SH; Kim C; Kim JH; Heo SJ; Park HS; Kim JH; Kim NK; Min BS; Kim H; Koom WS; Shin SJ
Br J Cancer; 2016 Jun; 115(1):25-33. PubMed ID: 27228287
[TBL] [Abstract][Full Text] [Related]
14. Elevated mean platelet volume predicts poor prognosis in colorectal cancer.
Li N; Yu Z; Zhang X; Liu T; Sun YX; Wang RT; Yu KJ
Sci Rep; 2017 Aug; 7(1):10261. PubMed ID: 28860547
[TBL] [Abstract][Full Text] [Related]
15. Predictive Value of Metabolic Parameters Derived From
Liu H; Ye Z; Yang T; Xie H; Duan T; Li M; Wu M; Song B
Front Immunol; 2021; 12():724464. PubMed ID: 34512653
[TBL] [Abstract][Full Text] [Related]
16. Lifestyle factors and risk of sporadic colorectal cancer by microsatellite instability status: a systematic review and meta-analyses.
Carr PR; Alwers E; Bienert S; Weberpals J; Kloor M; Brenner H; Hoffmeister M
Ann Oncol; 2018 Apr; 29(4):825-834. PubMed ID: 29438474
[TBL] [Abstract][Full Text] [Related]
17. Combined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancer.
Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Takahashi A; Kakuta M; Nishimura Y; Yamaguchi K
J Surg Oncol; 2014 Dec; 110(8):982-8. PubMed ID: 25154726
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome and Network Dissection of Microsatellite Stable and Highly Instable Colorectal Cancer.
Akbari V; Kallhor M; Mollashahi B; Movafagh A
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2445-2454. PubMed ID: 31450919
[TBL] [Abstract][Full Text] [Related]
19. Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry.
Chong LC; Townsend AR; Young J; Roy A; Piantadosi C; Hardingham JE; Roder D; Karapetis C; Padbury R; Maddern G; Moore J; Price TJ
Target Oncol; 2019 Feb; 14(1):85-91. PubMed ID: 30659494
[TBL] [Abstract][Full Text] [Related]
20. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
Marginean EC; Melosky B
Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]